Gene therapy shows promise for hemophiliacs
Hemophilia patients may benefit from a gene therapy technique that moderates or cures the bleeding disorder in mice and dogs, according to a study reported in the January issue of Nature Medicine.
Hemophilia patients may benefit from a gene therapy technique that moderates or cures the bleeding disorder in mice and dogs, according to a study reported in the January issue of Nature Medicine.